HERO Phase 3 Trial: Relugolix vs. Leuprolide Acetate for Advanced Prostate Cancer
21:55
The HERO Study and the Approval of Relugolix
15:31
Relugolix - Oral GnRH Antagonist
4:53
ASCO: Relugolix vs Leuprolide for Advanced Prostate Cancer
56:54
Latest Advances in Advanced Prostate Cancer Treatment | 2024 ZERO Prostate Cancer Summit
17:02
Androgen Deprivation Therapy and Prostate Cancer
24:15
ATM Heterozygotes: Cancer Risks and Management
6:37
Relugolix Plus Radiotherapy for Localized, Advanced Prostate Cancer
25:22